You are here

Janssen

Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

CP Wire

Bristol-Myers Squibb

Flag link:

Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

Bristol-Myers Squibb

Flag link:

Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices

Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices

Drug Channels

Flag link:

Janssen’s New Transparency Report: A Peek Behind the Drug Pricing Curtain Raises Troubling Questions About Rebates

Janssen’s New Transparency Report: A Peek Behind the Drug Pricing Curtain Raises Troubling Questions About Rebates

Drug Channels

Flag link:

A Possible Financial Boost Awaits Thousands Of Out-Of-State Plaintiffs In Risperdal suit

A Possible Financial Boost Awaits Thousands Of Out-Of-State Plaintiffs In Risperdal suit

Forbes

Flag link:

Beat you to it, Purdue. Other opioid makers already ditched promotions

Beat you to it, Purdue. Other opioid makers already ditched promotions

Fierce Pharma

Teva Pharmaceutical

Endo International

Flag link:

As CAR-Ts go from candidates to brands, what's the marketing strategy?

As CAR-Ts go from candidates to brands, what's the marketing strategy?

Medical Marketing and Media

Juno Therapeutics

Flag link:

Janssen Oncology rolls out Cancer.com, a website that's been years in the making

Janssen Oncology rolls out Cancer.com, a website that's been years in the making

Fierce Pharma

digital marketing

Flag link:

ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half

ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half

Fierce Pharma

Multiple Myeloma

Flag link:

Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo

Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo

Fierce Pharma

Flag link:

Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy

Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy

Yahoo/Reuters

Samsung Bioepis

rheumatoid arthritis

Flag link:

Don't give up on tough-to-treat depression, Janssen R&D says in new video push

Don't give up on tough-to-treat depression, Janssen R&D says in new video push

Fierce Pharma

clinical depression

Flag link:

Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar

Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar

First Word Pharma

Flag link:

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

Drug Channels

Flag link:

States Push Ahead With Investigation Into Opioid Painkillers

States Push Ahead With Investigation Into Opioid Painkillers

FOX Business

Endo International

Teva Pharmaceutical

Flag link:

J&J inks $879M vaccine deal with Bavarian Nordic

J&J inks $879M vaccine deal with Bavarian Nordic

BioPharma Dive

Bavarian Nordic

Flag link:

J&J touts first-in-human data for HIV vaccine

J&J touts first-in-human data for HIV vaccine

Drug Delivery Business News

Flag link:

Drug Companies Lose Challenge To Alliance Of Private Lawyers And State Officials

Drug Companies Lose Challenge To Alliance Of Private Lawyers And State Officials

Forbes

Endo Pharmaceuticals

Teva Pharmaceutical

Flag link:

Janssen gets EU nod for continuous manufacturing

Janssen gets EU nod for continuous manufacturing

BioPharma Dive

drug manufacturing

Flag link:

Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic

Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic

CNBC

Teva Pharmaceutical

Endo Health Solutions

Flag link:

Pages